132 related articles for article (PubMed ID: 23149498)
1. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).
Lindkvist B; Almquist M; Bjørge T; Stocks T; Borena W; Johansen D; Hallmans G; Engeland A; Nagel G; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
Cancer Causes Control; 2013 Jan; 24(1):107-16. PubMed ID: 23149498
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
Bjørge T; Lukanova A; Jonsson H; Tretli S; Ulmer H; Manjer J; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Häggström C; Stattin P; Engeland A
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1737-45. PubMed ID: 20615887
[TBL] [Abstract][Full Text] [Related]
3. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
[TBL] [Abstract][Full Text] [Related]
4. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
Häggström C; Stocks T; Rapp K; Bjørge T; Lindkvist B; Concin H; Engeland A; Manjer J; Ulmer H; Selmer R; Tretli S; Hallmans G; Jonsson H; Stattin P
Int J Cancer; 2011 Apr; 128(8):1890-8. PubMed ID: 20568111
[TBL] [Abstract][Full Text] [Related]
6. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
[TBL] [Abstract][Full Text] [Related]
7. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
Bjørge T; Lukanova A; Tretli S; Manjer J; Ulmer H; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Jonsson H; Häggström C; Stattin P; Engeland A
Int J Epidemiol; 2011 Dec; 40(6):1667-77. PubMed ID: 21984693
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and endometrial carcinoma.
Bjørge T; Stocks T; Lukanova A; Tretli S; Selmer R; Manjer J; Rapp K; Ulmer H; Almquist M; Concin H; Hallmans G; Jonsson H; Stattin P; Engeland A
Am J Epidemiol; 2010 Apr; 171(8):892-902. PubMed ID: 20219764
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study.
Edlinger M; Strohmaier S; Jonsson H; Bjørge T; Manjer J; Borena WT; Häggström C; Engeland A; Tretli S; Concin H; Nagel G; Selmer R; Johansen D; Stocks T; Hallmans G; Stattin P; Ulmer H
J Hypertens; 2012 Feb; 30(2):290-6. PubMed ID: 22179083
[TBL] [Abstract][Full Text] [Related]
10. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
[TBL] [Abstract][Full Text] [Related]
11. Prospective study on metabolic factors and risk of prostate cancer.
Häggström C; Stocks T; Ulmert D; Bjørge T; Ulmer H; Hallmans G; Manjer J; Engeland A; Nagel G; Almqvist M; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
Cancer; 2012 Dec; 118(24):6199-206. PubMed ID: 23090855
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
13. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can).
Almquist M; Johansen D; Björge T; Ulmer H; Lindkvist B; Stocks T; Hallmans G; Engeland A; Rapp K; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
Cancer Causes Control; 2011 May; 22(5):743-51. PubMed ID: 21380729
[TBL] [Abstract][Full Text] [Related]
14. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).
Stocks T; Lukanova A; Bjørge T; Ulmer H; Manjer J; Almquist M; Concin H; Engeland A; Hallmans G; Nagel G; Tretli S; Veierød MB; Jonsson H; Stattin P;
Cancer; 2011 Jun; 117(11):2398-407. PubMed ID: 24048787
[TBL] [Abstract][Full Text] [Related]
15. Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway.
Lu Y; Ness-Jensen E; Hveem K; Martling A
Am J Epidemiol; 2015 Nov; 182(10):883-93. PubMed ID: 26511906
[TBL] [Abstract][Full Text] [Related]
16. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study.
Steevens J; van den Brandt PA; Goldbohm RA; Schouten LJ
Gastroenterology; 2010 May; 138(5):1704-13. PubMed ID: 20006613
[TBL] [Abstract][Full Text] [Related]
17. Salt and gastric adenocarcinoma: a population-based cohort study in Norway.
Sjödahl K; Jia C; Vatten L; Nilsen T; Hveem K; Lagergren J
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1997-2001. PubMed ID: 18708389
[TBL] [Abstract][Full Text] [Related]
18. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
Johansen D; Stocks T; Jonsson H; Lindkvist B; Björge T; Concin H; Almquist M; Häggström C; Engeland A; Ulmer H; Hallmans G; Selmer R; Nagel G; Tretli S; Stattin P; Manjer J
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2307-17. PubMed ID: 20826833
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome is associated with gastric dysplasia.
Kim HY
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):871-5. PubMed ID: 21811159
[TBL] [Abstract][Full Text] [Related]
20. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
